Antimutagenic and some other effects of conjugated linoleic acid.
Conjugated linoleic acid (CLA) is a collective term for positional and geometric isomers of octadecadienoic acid in which the double bonds are conjugated, i.e. contiguous. CLA was identified as a component of milk and dairy products over 20 years ago. It is formed as an intermediate in the course of the conversion of linoleic acid to oleic acid in the rumen. The predominant naturally occurring isomer is the cis-9, trans-11 modification. Treatment of linoleic acid-rich oils such as safflower oil, soybean oil, or maize oil with base and heat will result in the formation of CLA. Two isomers predominate in the synthetic preparation, c9,t11 and t10,c12. CLA has been shown to inhibit chemically-induced skin, stomach, mammary or colon tumours in mice and rats. The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat. CLA has also been shown to inhibit cholesterol-induced atherosclerosis in rabbits. When young animals (mice, pigs) are placed on CLA-containing diets after weaning they accumulate more body protein and less fat. Since CLA is derived from the milk of ruminant animals and is found primarily in their meat and in products derived from their milk there is a concerted world-wide effort to increase CLA content of milk by dietary means. Its effect on growth (less fat, more protein) is also a subject of active research. The mechanisms underlying the effects of CLA are still moot.
Kritchevsky
D
D
Wistar Institute, Philadelphia, PA 19104, USA. kritchevsky@wistar.upenn.edu
D000818:Animals; D016587:Antimutagenic Agents / Q000737:chemistry / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000178:diet therapy / Q000517:prevention & control; D001823:Body Composition; D003110:Colonic Neoplasms / Q000178:diet therapy / Q000517:prevention & control; D003611:Dairy Products / Q000032:analysis*; D005260:Female; D019787:Linoleic Acid / Q000737:chemistry / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000178:diet therapy / Q000517:prevention & control; D051379:Mice; D008892:Milk / Q000737:chemistry; D011817:Rabbits; D051381:Rats; D012878:Skin Neoplasms / Q000178:diet therapy / Q000517:prevention & control
D016587:Antimutagenic Agents; D000970:Antineoplastic Agents; D019787:Linoleic Acid